Enhancement of oral bioavailability and solid dispersion: A review

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 7, 2011, Pages 13-20

  Saffoon, Nadia ^a   Uddin, Riaz ^b   Huda, Naz Hasan ^b   Sutradhar, Kumar Bishwajit ^b  

^a Marketing Strategy Department   (Bangladesh)

^b STAMFORD UNIVERSITY BANGLADESH   (Bangladesh)

Author keywords

Bioavailability; Biopharmaceutical classification; Carrier; Hot melt extrusion; Hot spin melting; Solubility

Indexed keywords

EID: 84864241991     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Adeyeye C.M., Price J.C. Development and evaluation of sustained-release ibuprofen-wax microspheres-II. In vitro dissolution studies. Pharm Res. 1994; 11(4): 575-579.
2. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995; 12(3): 413-420.
3. Bikiaris D., Papageorgiou G.Z., Stergiou A., Pavlidou E., Karavas E., Kanaze F. et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques. Thermochimica Acta. 2005; 439(1-2): 58-67
4. Breitenbach J., Lewis J. (2003). Two concepts, one technology: controlled release and solid dispersion with meltrex. In: Rathbone M.J., Hadgraft J., Roberts M.S. (Ed.) Modified-Release Drug Delivery Technology (pp. 125-134). USA: Marcel Dekker.
5. Ceballos A., Cirri M., Maestrelli F., Corti G., Mura P. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. IL Farmaco. 2005; 60(11-12): 913-918.
6. Chauhan B., Shimpi S., Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur J Pharm Sci. 2005; 26(2): 219- 230.
7. Chiou W.L., Reigelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971; 60(9): 1281-1302.
8. Chiou W.L., Riegelman S. Preparation and Dissolution Characteristics of Several Fast-Release Solid Dispersions of Griseofulvin. J Pharm Sci. 1969; 58(12): 1505-1510.
9. Chiou W.L., Riegelman, S. Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci. 1970; 59(7): 937-942.
10. Chokshi R.J., Zia H., Sandhu H.K., Shah N.H., Malick W.A. Improving the Dissolution Rate of Poorly Water Soluble Drug by Solid Dispersion and Solid Solution-Pros and Cons. Drug Delivery. 2007; 14(1): 33-45.
11. Corrigan, O.I. Mechanisms of dissolution of fast release solid dispersions. Drug Dev Ind Pharm. 1985; 11: 697-724.
12. Corrigan, O.I. Retardation of polymeric carrier dissolution by dispersed drugs: factors influencing the dissolution of solid dispersions containing polyethylene glycols. Drug Dev Ind Pharm. 1986; 12(11-13): 1777-1793.
13. Craig D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002; 231(2): 131- 144.
14. Dannenfelser R.M., He H., Joshi Y., Bateman S., Serajuddin A.T. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci. 2004; 93(5): 1165-1175.
15. Desai J., Alexander K., Riga A. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int J Pharm. 2006; 308(1-2): 115-123.
16. Dhirendra K., Lewis S., Udupa N., Atin K. Solid Dispersions: A Review. Pak J Pharm Sci. 2009; 22 (2): 234-246.
17. Dhumal R.S., Biradar S.V., Aher S., Paradkar A.R. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability. J Pharm Pharmacol. 2009; 61(6): 743-751.
18. Dittgen M., Fricke S., Gerecke H., Osterwald H. Hot spin mixing: a new technology to manufacture solid dispersions- part 1: testosterone. Pharmazie. 1995a; 50: 225-226.
19. Dittgen M., Fricke S., Gerecke H., Osterwald H. Hot spin mixing: a new technology to manufacture solid dispersions- part 3: progesterone. Pharmazie. 1995c; 50: 507-508.
20. Dittgen M., Graéser T., Kaufmann G., Gerecke H., Osterwald H., Oettel M. Hot spin mixing: a new technology to manufacture solid dispersions- part 2: dienogest. Pharmazie. 1995b; 50: 50-51.
21. Dobaria N.B., Mashru R.C., Badhan A.C., Thakkar A.R. A Novel Intravaginal Delivery System for Itraconazole: In Vitro and In Vivo Evaluation. Curr Drug Deliv. 2009; 6(2): 151-158.
22. El-Egakey M.A., M. Speiser S.P. Hot extruded dosage forms. Pharm Acta Helv. 1971; 46:31-52.
23. Engers D., Teng J., Jimenez-Novoa J., Gent P., Hossack S., Campbell C. et al. A solid-state approach to enable early development compounds: Selection and animal bioavailability studies of an itraconazole amorphous solid dispersion. J Pharm Sci. 2010; 99(9): 3901-3922.
24. FDA. Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms based on a Biopharmaceutics Classification System. 2000. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInf ormation/Guidances/ucm070246.pdf [Accessed on: September 2, 2011].
25. Ford J.L. The current status of solid dispersions. Pharm Acta Helv. 1986; 61:69-88.
26. Gao P., Morozowich W. Development of supersaturatable selfemulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006; 3(1): 97-110.
27. García-Zubiri I.X., González-Gaitano G., Isasi J.R. Thermal stability of solid dispersions of naphthalene derivatives with [beta]- cyclodextrin and [beta]-cyclodextrin polymers. Thermochim Acta. 2006; 444 (1): 57-64.
28. Ghorab M.K., Adeyeye M.C. Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin. Pharm Dev Technol. 2001; 6(3): 305-314.
29. Goddeeris C., Willems T., Houthoofd K., Martens J.A., Van den Mooter G. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm. 2008; 70(3): 861-868.
30. Goldberg A.H., Gibaldi M., Kanig J.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures III - experimental evaluation of griseofulvin-succinic acid solid solution. J Pharm Sci. 1966b; 55: 487-492.
31. Goldberg A.H., Gibaldi M., Kanig J.L., Mayersohn M. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol- urea system. 1966a; J Pharm Sci. 55: 581-583.
32. Goldberg A.H., Gibaldi M., Kanig, J.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I-theoretical considerations and discussion of the literature. J Pharm Sci. 1965; 54:1145-1148.
33. Gupta M.K., Tseng Y.C., Goldman D., Bogner R.H. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res. 2002; 19(11): 1663-1672.
34. Guyot M., Fawaz F., Bildet J., Bonini F., Lagueny A. -M. Physicochemical characterization and dissolution of Roth W., Setnik B., Zietsch M., Burst A., Breitenbach J., Sellers E. et al. Ethanol effects on drug release from Verapamil Meltrex®, an innovative melt extruded formulation. Int J Pharm. 2009; 368(1-2): 72-75.
35. Sahoo J., Murthy P. N., Biswal S., Manik. Formulation of Sustained-Release Dosage Form of Verapamil Hydrochloride by Solid Dispersion Technique Using Eudragit RLPO or Kollidon®SR. AAPS PharmSciTech. 2009; 10(1): 27-33.
36. Sekiguchi K., Obi N. Studies on Absorption of Eutectic Mixture. II. Absorption of Fused Conglomerates of Chloramphenicol and Urea in Rabbits. Chem Pharm Bull (Tokyo). 1964; 12: 134-144.
37. Sekiguchi K., Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharmaceut Bull. 1961; 9:866-872.
38. Seo A., Holm P., Kristensen H.G., Schaefer T. The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. Int J Pharm. 2003; 259(1-2): 161- 171.
39. Serajuddin A.T.M. Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs. J Pharm Sci. 1999; 88(10):1058-1066.
40. Shakhtshneider T.P., Vasiltchenko M.A., Politov A.A., Boldyrev V.V. The mechanochemical preparation of solid disperse systems of ibuprofen-polyethylene glycol. Int J Pharm. 1996; 130: 25-32.
41. Shinde V.R., Shelake M.R., Shetty S.S., Chavan-Patil A.B., Pore1 Y.V., Late S.G. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. J Pharm Pharmacol. 2008; 60(9): 1121-1129.
42. Simonelli A.P., Mehta S.C., Higuchi W.I. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci. 1969; 58: 538-549.
43. Sriamornsak P., Kontong S., Weerapol Y., Nunthanid J., Sungthongjeen S., Limmatvapirat S. Manufacture of Ternary Solid Dispersions Composed of Nifedipine, Eudragit® E and Adsorbent. Advanced Materials Research. 2011; 317 - 319: 185-188.
44. Srinarong P., Faber J.H., Visser M.R., Hinrichs W.L.J., Frijlink H.W. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm. 2009; 73(1): 154-161.
45. Sun N., Wei X., Wu B., Chen J., Lu Y., Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powder Technology. 2008; 182(1): 72-80.
46. Tachibana T., Nakamura A. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: dispersion of beta-carotene by polyvinylpyrrolidone. Colloid & Polymer Science. 1965; 203(2):130-133.
47. Tanaka N., Imai K., Okimoto K., Ueda S., Tokunaga Y., Ibuki R., et al. Development of novel sustained-release system, disintegrationcontrolled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. J Contr Release. 2006; 112(1): 51-56.
48. Tanaka N., Imai K., Okimoto K., Ueda S., Tokunaga Y., Ohike A. et al. Development of novel sustained-release system, disintegrationcontrolled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Contr Release. 2005; 108 (2-3): 386-395.
49. Tang J., Sun J., He Z.G. Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Current Drug Therapy. 2007; 2(1): 85-93.
50. Taylor L.S., Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1997 14(12): 1691-1698.
51. Tiwari G., Tiwari R., Srivastava B., Rai A.K. Development and optimization of multi-unit solid dispersion systems of poorly water soluble drug. Research J Pharm and Tech. 2008; 1(4): 444-449.
52. Tran H.T., Park J.B., Hong K.H., Choi H.G., Han H.K., Lee J. et al. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug. Int J Pharm. 2011; 415(1-2):83-8.
53. Uddin R., Saffoon N., Huda N.H., Jhanker Y.M. Effect of Water Soluble Polymers on Dissolution Enhancement of Ibuprofen Solid Dispersion Prepared by Fusion Method. Stamford Journal of Pharmaceutical Sciences. 2010; 3(1): 63-67
54. Urbanetz, N.A. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci. 2006; 28(1-2): 67-76.
55. Van den Mooter G., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P. et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001; 12(3): 261-269.
56. van Drooge D.J., Braeckmans K., Hinrichs W.L.J., Reniant K., de Smedt S.C., Frijlink H.W. Characterization of the Mode of Incorporation of Lipophilic Compounds in Solid Dispersions at the Nanoscale Using Fluorescence Resonance Energy Transfer (FRET). Macromol Rapid Commun. 2006b; 27(14): 1149-1155.
57. van Drooge D.J., Hinrichs W.L., Visser M.R., Frijlink H.W. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm. 2006a; 310(1-2): 220-229.
58. Vasanthavada M., Tong W.Q., Joshi Y., Kislalioglu M.S. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility. Pharm Res. 2004; 21(9): 1598- 1606.
59. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007; 12 (23/24): 1068-1075.
60. Verreck G., Decorte A., Heymans K., Adriaensen J., Cleeren D., Jacobs A. et al. The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64. Eur J Pharm Sci. 2005; 26(3-4): 349-358.
61. Verreck G., Decorte A., Heymans K., Adriaensen J., Liu D., Tomasko D. et al. Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. Int J Pharm. 2006; 327(1-2): 45-50.
62. Vilhelmsen T., Eliasen H., Schaefer T. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int J Pharm. 2005; 303(1-2): 132-142.
63. Vippagunta S.R., Wang Z., Hornung S., Krill S.L. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci. 2007; 96(2): 294-304.
64. Wacker S., Soliva M., Speiser P. Injection molding as a suitable process for manufacturing solid dispersions or solutions, Pharmazeutische Industrie. 1991; 53: 853-856.
65. Wang X., Michoel A., Van den Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm. 2005; 303(1-2): 54-61.
66. Wiranidchapong C., Tucker I.G., Rades T., Kulvanich P. Miscibility and interactions between 17ß-estradiol and Eudragit® RS in solid dispersion. J Pharm Sci. 2008; 97(11): 4879-4888.
67. Won D.H., Kim M.S., Lee S., Park J.S., Hwang S.J. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm. 2005; 301(1- 2): 199-208.
68. Yao R., Liu L., Deng S., Ren W. Preparation of Carboxymethylchitosan Nanoparticles with Acid-Sensitive Bond Based on Solid Dispersion of 10-Hydroxycamptothecin. ISRN Pharmaceutics. 2011; Article ID 624704. Available at: http://www.isrn.com/journals/ pharmaceutics/2011/624704/ [Accessed on: September 5, 2011].
69. Yao W.-W., Bai T.-C., Sun J.-P, Zhu C.-W., Hu J., Zhang H.-L. Thermodynamic properties for the system of silybin and poly(ethylene glycol) 6000. Thermochim Acta. 2005; 437(1-2): 17-20.
70. Ying L., Jiang C., Meihua H., Xueying Y., Xiangtao W. Preparation and in Vitro Release Evaluation of Isoniazid Solid Dispersion. Chinese Journal of Modern Applied Pharmacy. 2011. Issue 02. Abstract available at: http://en.cnki.com.cn/Article_en/CJFDTOTALXDYD201102015. htm [Accessed on: September 5, 2011].
71. Yoshihashi Y., Iijima H., Yonemochi E., Terada K. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J Therm Anal Calorim. 2006; 85(3): 689-692.
72. Yüksel N., Karatas A., Ozkan Y., Savaser A., Ozkan S.A., Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2003; 56(3): 453-459.